Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.
Related Posts
Trump’s Tariffs and Tax Bill May Derail U.S. Battery Industry
Domestic factories that make batteries to store power to meet America’s rising energy demand depend on Chinese components and federal subsidies.
San Francisco Art Institute, With Diego Rivera Mural, Is Sold to Nonprofit
The main campus of the bankrupt San Francisco Art Institute, which is home to a beloved Diego Rivera mural, has been sold to a new […]
What are the top benefits of using ai for small businesses?
ai for small businesses AI for small businesses is transforming the way companies operate, providing advanced automation solutions that help streamline processes, reduce costs, and […]